INKT·603693201·US·equity·Healthcare - Biotechnology
INKT (MINK THERAPEUTICS INC) is held by 11 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($182,666), UBS Group AG ($160,077), BlackRock, Inc. ($65,317). Net institutional sentiment: Mixed.
See how INKT's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer